Compare ADCT & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADCT | MED |
|---|---|---|
| Founded | 2011 | 1980 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.1M | 122.8M |
| IPO Year | 2019 | 1996 |
| Metric | ADCT | MED |
|---|---|---|
| Price | $1.27 | $10.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $7.75 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.5M | 280.9K |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $81,357,000.00 | ★ $934,842,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $66.49 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 14.85 | N/A |
| 52 Week Low | $0.78 | $9.22 |
| 52 Week High | $4.98 | $15.37 |
| Indicator | ADCT | MED |
|---|---|---|
| Relative Strength Index (RSI) | 40.09 | 37.02 |
| Support Level | $0.78 | $10.01 |
| Resistance Level | $1.44 | $11.03 |
| Average True Range (ATR) | 0.11 | 0.35 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 60.67 | 20.37 |
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.